A Randomized Observer Blinded Controlled Non Inferiority Trial to Evaluate the Safety and Immunogenicity of Locally Manufactured Inactivated Bivalent Whole Cell-oral Cholera Vaccine (WC-OCV) 'Cholvax' in Bangladeshi Healthy Adults and Children
Latest Information Update: 06 Jan 2022
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Adverse reactions; Pharmacodynamics
- 27 Dec 2021 Primary endpoint (Number of participants showing seroconversion against serogroup V. cholerae O1) has been met, as per results published in the Vaccine.
- 27 Dec 2021 Results published in the Vaccine
- 15 Jun 2017 Status changed from recruiting to completed.